On the recordJune 9, 2021
Transparency in the FDA's process of reviewing and approving potential therapies for ALS is also of the upmost importance.
Source
congress.govEditor's note · Context
Leahy stresses the importance of FDA transparency for ALS therapies.
Share
More from Patrick Leahy
Sep 15, 2022
on May 19, I echoed Secretary of State Blinken's call for an ``independent, credible investigation'' of the violent death of widely respected Palestinian-American journalist Shireen Abu Akleh. At that time, several Members of Congress…
Dec 22, 2022
throughout my 48 years in the Senate, I worked to uphold the American tradition of a humane immigration policy and fought to advance comprehensive immigration reform. As an advocate for refugees and asylum seekers fleeing violence and…
Dec 13, 2022
I have spent more than 30 years working to build closer relations with Vietnam, a country where 58,220 Americans and an estimated 3 million Vietnamese died in a war that never should have been fought. In 1975, as the newest member of the…
Nov 15, 2022
a few minutes ago, before I opened the Senate, I had the privilege of walking on the floor with Senator-elect Peter Welch of Vermont. I am going to speak more about our new Senator, who will be taking this seat very shortly, within the…
Other voices in this conversation
